Traversing the Quality Chasm: Revisiting the Framework for Pharmacy Services Quality Improvement [0.03%]
跨越质量鸿沟：重新审视药学服务质量管理的框架
Mel L Nelson,Carter Chapman,Patrick J Campbell
Mel L Nelson
No funding supported the writing of this reflection. The authors have nothing to disclose.
Real-World Clinical and Economic Outcomes Associated with Palbociclib for HR-Positive/HER2 Negative Metastatic Breast Cancer: A Commentary [0.03%]
帕博西尼治疗HR阳性/HER2阴性转移性乳腺癌的临床及经济效益分析：短评
Aram Babcock,Askal Ayalew Ali,Rajesh Balkrishnan et al.
Aram Babcock et al.
Despite the achieved advancement in pharmacological cancer treatments, the majority of postmenopausal women with hormone receptor-positive metastatic breast cancer (mBC) will experience disease progression. Research into alternative therapi...
Evaluation of a Pharmacist-Managed Nonsteroidal Anti-Inflammatory Drugs Deprescribing Program in an Integrated Health Care System [0.03%]
一种药师管理的非甾体抗炎药减药计划在一体化卫生保健系统的评估研究
Rezoana Rashid,Christopher Chang,Fang Niu et al.
Rezoana Rashid et al.
Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to treat symptoms of chronic inflammatory diseases such as osteoarthritis and rheumatoid arthritis; however, they are also associated with variou...
Assessing the Population-Level Correlation of Medication Regimen Complexity and Adherence Indices Using Electronic Health Records and Insurance Claims [0.03%]
基于电子健康记录和保险理赔数据评估用药方案复杂性与依从性指标的群体相关性
Xiaomeng Ma,Changmi Jung,Hsien-Yen Chang et al.
Xiaomeng Ma et al.
Background: Nonadherence to medication regimens can lead to adverse health care outcomes and increasing costs. Objectives: To (a) asses...
Caroline Forrester
Caroline Forrester
No funding supported the writing of this article. The author has nothing to disclose.
Framework for Pharmacy Services Quality Improvement-A Bridge to Cross the Quality Chasm [0.03%]
药学服务质量管理改进框架——跨越质量鸿沟的桥梁
Frederic R Curtiss,Richard N Fry,Steven G Avey
Frederic R Curtiss
Objective: To review the literature on the subject of quality improvement principles and methods applied to pharmacy services and to describe a framework for current and future efforts in pharmacy services quality improve...
Real-World Assessment of Health Care Costs for Patients with Metastatic Pancreatic Cancer Following Initiation of First-Line Chemotherapy [0.03%]
一线化疗后转移性胰腺癌患者医疗费用的现实世界评估
Andrea Bullock,Christopher G Rowan,Nina Oestreicher et al.
Andrea Bullock et al.
Background: Management of metastatic pancreatic ductal adenocarcinoma (mPDA) places a significant financial burden on the U.S. health care system because of such factors as treatment with multidrug chemotherapy regimens, ...
Development and Implementation of Clinical Outcome Measures for Automated Collection Within Specialty Pharmacy Practice [0.03%]
专科药房实践中自动收集临床结果测量的开发与实施
Katherine Patel,Yee-Ling Chim,Jonathan Grant et al.
Katherine Patel et al.
Background: Johns Hopkins Specialty Pharmacy Services recognized the need to identify and develop standardized collection methods for clinical outcome measures (COMs) to demonstrate program quality and value to third-part...
Changes in Cost-Effectiveness for Chronic Hepatitis C Virus Pharmacotherapy: The Case for Continuous Cost-Effectiveness Analyses [0.03%]
慢性丙型肝炎病毒药物治疗的成本效益变化：持续成本效益分析的必要性
T Joseph Mattingly nd,Bryan L Love
T Joseph Mattingly nd
Background: Cost-effectiveness evaluations for hepatitis C virus (HCV) treatments have been published frequently, but new products with significant cost and effectiveness differences make these analyses obsolete. How valu...
Indications for Rituximab Use in an Integrated Health Care Delivery System [0.03%]
利妥昔单抗在一个综合医疗服务系统中的使用指征
Thomas Delate,Margaret L Hansen,Amarylis C Gutierrez et al.
Thomas Delate et al.
Background: Rituximab is a top-selling biologic that was first approved by the FDA in 1997 for a non-Hodgkin lymphoma orphan indication. It has since been approved for additional orphan indications, with rheumatoid arthri...